Search By

Format
Articles (57)Events (14)News (486)Interviews (3)
Publication Date
Last 3 months Last 6 months Last 12 months

486 Results

Search By

ArticlesEventsNewsInterviews

Collaboration

Alvotech Appoints DNB Carnegie As Liquidity Provider For SDRs On Nasdaq Stockholm

Alvotech appoints DNB Carnegie as liquidity provider for its SDRs on Nasdaq Stockholm to enhance trading stability.

Vaibhavi M. | May 20, 2025

Innovation

Rejuvenate Biomed Doses First Patient in Phase 2 COPD Muscle Weakness Trial of RJx-01

Rejuvenate Biomed begins Phase 2 trial of RJx-01 to treat sarcopenia in COPD patients, targeting aging mechanisms for muscle health..

Vaibhavi M. | May 20, 2025

Innovation

Chugai Wins Taiwan Approval For PiaSky® To Treat PNH Based On Global COMMODORE Trial Data

Chugai’s PiaSky® approved in Taiwan for PNH treatment, offering 4-week subcutaneous dosing using Recycling Antibody® tech.

Vaibhavi M. | May 20, 2025

Collaboration

Daiichi Sankyo And Merck Dose First Patient In IDeate-Esophageal01 Study For Advanced Esophageal Squamous Cell Carcinoma Patients

Daiichi Sankyo & Merck begin Phase 3 trial of I-DXd in advanced esophagal cancer after promising early-phase results.

Vaibhavi M. | May 20, 2025

Accquisition

Regeneron to Acquire 23andMe’s Key Assets for $256 Million, Expanding Genetic Data Capabilities

Regeneron acquires 23andMe’s core assets for $256M, ensuring continued genome services and enhanced genetic research.

Simantini Singh Deo | May 20, 2025

Innovation

AstraZeneca’s Airsupra Shines in BATURA Trial, Offering New Hope for Mild Asthma Management

AstraZeneca's Airsupra shows superior efficacy over albuterol in mild asthma, per Phase IIIb BATURA trial results.

Simantini Singh Deo | May 20, 2025

Innovation

Chugai Wins Taiwan Approval For PiaSky® To Treat PNH Based On Global COMMODORE Trial Data

Chugai's Vabysmo approved in Japan as the first treatment for vision loss from angioid streaks.

Vaibhavi M. | May 19, 2025